- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| So | Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating | 2 | Insider Monkey | |
| Fr | Goldman Sachs stuft Beta Bionics-Aktie mit Neutral-Rating und Kursziel von 16 US-Dollar ein | 5 | Investing.com Deutsch | |
| Fr | Goldman Sachs sets Beta Bionics stock at Neutral with $16 target | 2 | Investing.com | |
| 07.05. | Beta Bionics Q1 2025 slides: raised guidance despite earnings miss | 3 | Investing.com | |
| 06.05. | Beta Bionics GAAP EPS of -$0.93 misses by $0.46, revenue of $17.6M beats by $1.45M | 2 | Seeking Alpha | |
| 06.05. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | |
| 06.05. | Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 | 452 | GlobeNewswire (Europe) | |
| BETA BIONICS Aktie jetzt für 0€ handeln | ||||
| 16.04. | Beta Bionics, Inc.: Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 | 1 | GlobeNewswire (USA) | |
| 09.04. | Beta Bionics, Inc.: Beta Bionics to Host Investor Event on June 22, 2025 | 2 | GlobeNewswire (USA) | |
| 04.04. | Stifel maintains Buy rating on Beta Bionics stock, target at $25 | 6 | Investing.com | |
| 28.03. | Beta Bionics, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | |
| 27.03. | Beta Bionics appoints new board member from Delcath Systems | 1 | Investing.com | |
| 27.03. | Beta Bionics ernennt neues Vorstandsmitglied von Delcath Systems | 4 | Investing.com Deutsch | |
| 27.03. | Beta Bionics, Inc.: Beta Bionics Announces Board Appointment of Gerard Michel | 1 | GlobeNewswire (USA) | |
| 26.03. | Piper Sandler maintains $26 target on Beta Bionics stock | 1 | Investing.com | |
| 25.03. | Beta Bionics, Inc. - 10-K, Annual Report | 2 | SEC Filings | |
| 25.03. | Beta Bionics posts Q4 sales beat to cap off 'momentum-building year' | 2 | MassDevice | |
| 25.03. | Beta Bionics GAAP EPS of -$2.72 misses by $1.63, revenue of $20.44M beats by $0.25M | 1 | Seeking Alpha | |
| 25.03. | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 | 230 | GlobeNewswire (Europe) | |
| 25.03. | Beta Bionics, Inc. - 8-K, Current Report | 2 | SEC Filings |
Seite:
1 2 3 Weiter >>
56 Nachrichten in den letzten 12 Monaten
Das Unternehmen BETA BIONICS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 18,670 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BETA BIONICS INC finden Sie auf Wallstreet Online.